As of Friday close, Replimune Group Inc.’s (NASDAQ:REPL) stock was down -$0.08, moving down -0.41 percent to $19.60. The average number of shares traded per day over the past five days has been 1,261,200 shares. 2 times new highs have been achieved over the past 5 days, with a $0.95 gain in that time frame. In the last twenty days, the average volume was 819,510, while in the previous 50 days, it was 586,782.
Since last month, REPL stock retreated -20.49%. Shares of the company fell to $18.34 on 03/10/23, the lowest level in the past month. A 52-week high of $29.52 was reached on 02/02/23 after having rallying from a 52-week low of $13.05. Since the beginning of this year, REPL’s stock price has dropped by -27.94% or -$7.60, and marked a new high 4 times. However, the stock has declined by -33.61% since its 52-week high.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
REPL stock investors should be aware that Replimune Group Inc. (REPL) stock had its last reported insider trading activity 99 days ago on Dec 09. Esposito Pamela, the Chief Business Officer of the company, disposed of 15,000 shares for $25.03 on Dec 09. It resulted in a $375,450 divestment by the insider. Patel Sushil sold 10,687 shares at an average price of $14.59 on May 16. The insider now owns 130,146 shares following the transaction. On May 16, Chief Executive Officer Astley-Sparke Philip sold 9,632 shares at $14.59 apiece. The transaction was valued at $140,531.
In the three months ended December 30, Replimune Group Inc.’s quick ratio stood at 23.60, while its current ratio was 23.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending December 30 was 0.09, and the total debt-to-equity ratio was 0.09. Based on annual data, REPL earned $2.22 million in gross profit and brought in $118.31 million in revenue.
In Replimune Group Inc.’s quarter-end financial report for December 30, it reported total debt of $28.39 million against cash and short-term investments of $409.71 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. While analysts expected Replimune Group Inc. to report -$0.75 quarterly earnings, the actual figure was -$0.69 per share, beating the consensus estimate by 8.00%. During the quarter, the company generated -$42.57 million in EBITDA. The liabilities of Replimune Group Inc. were 83.2 million at the end of its most recent quarter ended December 30, and its total debt was $60.4 million. The value of shareholders’ equity is $56.66 million.
This quick technical analysis looks at Replimune Group Inc.’s (REPL) price momentum. With a historical volatility rate of 56.34%, the RSI 9-day stood at 34.68% on 17 March.
With respect to its five-day moving average, the current Replimune Group Inc. price is up by +5.09% percent or $0.95. At present, REPL shares trade -19.21% below its 20-day simple moving average and +2.30% percent above its 100-day simple moving average. However, the stock is currently trading approximately -25.33% below its SMA50 and +34.89% above its SMA200.
Stochastic coefficient K was 27.30% and Stochastic coefficient D was 25.52%, while ATR was 1.17. Given the Stochastic reading of 28.83% for the 14-day period, the RSI (14) reading has been calculated as 35.16%. As of today, the MACD Oscillator reading stands at -0.41, while the 14-day reading stands at -1.17.
Piper Sandler launched its rating on Replimune Group Inc. (NASDAQ: REPL) to an Overweight in a note to investors on November 19, 2021. Replimune Group Inc. (REPL) has been rated Buy by analysts. According to 0 brokerage firms, REPL is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Replimune Group Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $50.00, the current consensus forecast for the stock is $34.00 – $70.00. Based on these forecasts, analysts predict Replimune Group Inc. (REPL) will achieve an average price target of $51.44.